OncoMed Pharmaceuticals SVP/CFO on Emerging Company Capital Formation Testimony

Type:

Video

William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals, highlights the importance of capital formation to encourage investment in the biotechnology industry and spur job growth. Mr. Waddill provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs hearing.

February 12, 2013 Tales From the Wild West (Wing): Reflections from White House Chiefs of Staff Featuring John Podesta & Joshua Bolton	February 12, 2013 Fireside Chat With Jean-Jacques Bienaimé, Chief Executive Officer, BioMarin	February 12, 2013 Orphan Drugs: Making Rare Disease Rarer	February 8, 2013 Kimball Thomson, President & CEO at BioUtah
February 7, 2013 The Biotech Hall of Fame Awards: Biotech's First Investment Banker	January 21, 2013 BIO's 2013 Legislative Priorities	December 20, 2012 2012 BIO International Convention Governors Highlight Reel	September 18, 2012 Encouraging Adult Vaccination: William Schaffner, MD